Résumé
The efficacy of Muravvaq of Mako [Frothless juice of Aolanum nigrum leaves] to control hepatic damage induces by Rifampicin was studied in Wistar albino rats. Rifampicin was administered orally as suspension to rats with a daily dose of 50 mg/kg body weight till 30 days with Muravvaq of Mako in concurrent group. In the second phase of study the effect of Muravvaq on established hepatotoxicity was studied by giving it for 20 days after withdrawal of Rifampicin. Hepatic dysfunction was assessed by biochemical and histological parameters. A significant increase observed in serum bilirubin, SGOT, SGPT and Alkaline phosphatase levels in negative control groups. However, there was a significant reduction in increased enzymatic levels in concurrent and treated group of rats, which received Muravvaq alongwith Rifampicin for 30 and 50 days, respectively. Histopathological analysis of liver samples also confirmed the hepatoprotective effect of Muravvaq. These results suggest that Muravvaq of Mako shows hepatoprotective effect against Rifampicin-induced hepatic damage in rats. The study was done in two different seasons, just after rainy [August-September] and in autumn season, to assess the efficacy of seasonal variation
Sujets)
Mâle , Femelle , Animaux de laboratoire , Plantes médicinales , Extraits de plantes , Feuilles de plante , Lésions hépatiques dues aux substances/prévention et contrôle , Rat Wistar , Rifampicine/effets indésirables , Rifampicine/toxicité , Médecine unaniRésumé
Popularity of Aromatherapy has attracted worldwide attention. Unani system of medicine with its speciality in use of aromatic drugs may also contribute to Aromatherapy debate effectively. It is in this context that a review of Aromatic drugs of Unani medicine is being presented here to cause awareness about the aromatic drugs of authentic utility employed in Unani medicine
Résumé
Khar-e-Khasak Khurd [Tribulus terrestris Linn, fruit] is used for treating sexual dysfunctions in the Unani System of Medicine. The effects of aqueous extract of drug were studied on sexual behaviour of male rats. In this study copulatory behaviour, penile erection, licking, grooming of genitals and copulatory movement in absence of female rats were observed. Androgenic and anabolic activities were also assessed by recording the weight of ventral prostate and levator ani muscle. The results show that test drug 500 mg/kg orally produced a significant increase in mounting frequency by 54%, Intromission frequency by 87%, mounting latency by 92%, Intromission latency by 107%, ejaculatory latency by 52% and post-ejaculatory interval by 24%. The drug produced significant increase in penile erection index, weight of prostate and levator ani muscles by 73% and 51.6%. This study supports the use of this drug in treatment of impotence, premature ejaculation and depressed libido